Kallikrein 15 anticorps (AA 75-87)
Aperçu rapide pour Kallikrein 15 anticorps (AA 75-87) (ABIN636239)
Antigène
Voir toutes Kallikrein 15 (KLK15) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 75-87
-
Réactivité croisée (Details)
- This antibodys immunogens shares 92 % sequence identity with its Mouse, and rat homologs.
-
Purification
- Affinity chromatography purified
-
Immunogène
- KLK15 antibody was raised in rabbit using AA 75-87 [HNLRKRDGPEQLR] of the 28 kDa human KLK15 protein as the immunogen.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- Kallikrein 15 (KLK15) (Kallikrein-Related Peptidase 15 (KLK15))
-
Autre désignation
- KLK15
-
Sujet
- This is a novel human kallikrein gene. Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. KLK15 is up-regulated in more aggressive forms of prostate cancer, which indicates its potential use as a diagnostic or prognostic marker for prostate cancer. The gene contains multiple polyadenylation sites and is alternatively spliced. Four splice variants, each encoding a distinct isoform, have been described.
-
Pathways
- Système du Complément
Antigène
-